Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. AJ Baker, A Mooney, J Hughes, D Lombardi, RJ Johnson, J Savill The Journal of clinical investigation 94 (5), 2105-2116, 1994 | 515 | 1994 |
Does narrative information bias individual's decision making? A systematic review A Winterbottom, HL Bekker, M Conner, A Mooney Social science & medicine 67 (12), 2079-2088, 2008 | 464 | 2008 |
p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis A Schürmann, AF Mooney, LC Sanders, MA Sells, HG Wang, JC Reed, ... Molecular and cellular biology 20 (2), 453-461, 2000 | 458 | 2000 |
Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic … JA Hussain, A Mooney, L Russon Palliative medicine 27 (9), 829-839, 2013 | 236 | 2013 |
Renal association clinical practice guideline on haemodialysis D Ashby, N Borman, J Burton, R Corbett, A Davenport, K Farrington, ... BMC nephrology 20, 1-36, 2019 | 207 | 2019 |
Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy. J Floege, W Kriz, M Schulze, M Susani, D Kerjaschki, A Mooney, ... The Journal of clinical investigation 96 (6), 2809-2819, 1995 | 178 | 1995 |
Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR<45 mL/min/1.73 m2): a summary document … K Farrington, A Covic, I Nistor, F Aucella, N Clyne, L De Vos, A Findlay, ... Nephrology Dialysis Transplantation 32 (1), 9-16, 2017 | 150 | 2017 |
Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2) K Farrington, A Covic, F Aucella, N Clyne, L De Vos, A Findlay, D Fouque, ... Nephrology Dialysis Transplantation 31 (suppl_2), ii1-ii66, 2016 | 135 | 2016 |
Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via β1 integrin-mediated survival signals A Mooney, K Jackson, R Bacon, C Streuli, G Edwards, J Bassuk, J Savill The American journal of pathology 155 (2), 599-606, 1999 | 117 | 1999 |
Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis. J Hughes, RJ Johnson, A Mooney, C Hugo, K Gordon, J Savill The American journal of pathology 150 (1), 223, 1997 | 115 | 1997 |
Choosing dialysis modality: decision making in a chronic illness context A Winterbottom, HL Bekker, M Conner, A Mooney Health Expectations 17 (5), 710-723, 2014 | 100 | 2014 |
Patient acceptability of the Yorkshire Dialysis Decision Aid (YoDDA) booklet: a prospective non-randomized comparison study across 6 predialysis services AE Winterbottom, T Gavaruzzi, A Mooney, M Wilkie, SJ Davies, D Crane, ... Peritoneal Dialysis International 36 (4), 374-381, 2016 | 97 | 2016 |
Patient stories about their dialysis experience biases others’ choices regardless of doctor’s advice: an experimental study AE Winterbottom, HL Bekker, M Conner, AF Mooney Nephrology Dialysis Transplantation 27 (1), 325-331, 2012 | 91 | 2012 |
Apoptosis and renal scarring. J Savill, A Mooney, J Hughes Kidney international. Supplement 54, S14-7, 1996 | 75 | 1996 |
The terminal sequence of complement plays an essential role in antibody-mediated renal cell apoptosis T Sato, MGA Van Dixhoorn, FA Prins, A Mooney, N Verhagen, Y Muizert, ... Journal of the American Society of Nephrology 10 (6), 1242-1252, 1999 | 74 | 1999 |
Cytokines promote glomerular mesangial cell survival in vitro by stimulus-dependent inhibition of apoptosis. A Mooney, T Jobson, R Bacon, M Kitamura, J Savill Journal of immunology (Baltimore, Md.: 1950) 159 (8), 3949-3960, 1997 | 71 | 1997 |
Evaluating the quality of patient leaflets about renal replacement therapy across UK renal units A Winterbottom, M Conner, A Mooney, HL Bekker Nephrology Dialysis Transplantation 22 (8), 2291-2296, 2007 | 60 | 2007 |
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation MPW Smith, A Zougman, DA Cairns, M Wilson, T Wind, SL Wood, ... Kidney international 84 (6), 1214-1225, 2013 | 57 | 2013 |
Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety. M Burg, T Ostendorf, A Mooney, KM Koch, J Floege Laboratory investigation; a journal of technical methods and pathology 76 (4 …, 1997 | 52 | 1997 |
Quality standards for predialysis education: results from a consensus conference C Isnard Bagnis, C Crepaldi, J Dean, T Goovaerts, S Melander, ... Nephrology Dialysis Transplantation 30 (7), 1058-1066, 2015 | 48 | 2015 |